These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 1634602)

  • 1. Transforming growth factor-beta in disease: the dark side of tissue repair.
    Border WA; Ruoslahti E
    J Clin Invest; 1992 Jul; 90(1):1-7. PubMed ID: 1634602
    [No Abstract]   [Full Text] [Related]  

  • 2. TGF-beta in renal injury and disease.
    Böttinger EP
    Semin Nephrol; 2007 May; 27(3):309-20. PubMed ID: 17533008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunopharmacological properties of transforming growth factor beta.
    Le Y; Yu X; Ruan L; Wang O; Qi D; Zhu J; Lu X; Kong Y; Cai K; Pang S; Shi X; Wang JM
    Int Immunopharmacol; 2005 Dec; 5(13-14):1771-82. PubMed ID: 16275614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-transforming growth factor antibody at low but not high doses limits cyclosporine-mediated nephrotoxicity without altering rat cardiac allograft survival: potential of therapeutic applications.
    Khanna AK; Plummer MS; Hilton G; Pieper GM; Ledbetter S
    Circulation; 2004 Dec; 110(25):3822-9. PubMed ID: 15583082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular biology in regulation of kidney function: TGF-beta (transforming growth factor-beta)].
    Tamaki K; Yoshimura J; Okuda S
    Nihon Rinsho; 2006 Feb; 64 Suppl 2():297-301. PubMed ID: 16523906
    [No Abstract]   [Full Text] [Related]  

  • 6. Transforming growth factor-beta and organ transplantation.
    Waltenberger J; Miyazono K; Funa K; Wanders A; Fellström B; Heldin CH
    Transplant Proc; 1993 Apr; 25(2):2038-40. PubMed ID: 8470265
    [No Abstract]   [Full Text] [Related]  

  • 7. [TGF-beta: usage in nephrology].
    Quirin N; Feige JJ; Zaoui P
    Nephrologie; 1996; 17(4):227-35. PubMed ID: 8768454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-beta: a cytokine mediator of glomerulosclerosis and a target for therapeutic intervention.
    Border WA; Noble NA; Ketteler M
    Kidney Int Suppl; 1995 Jun; 49():S59-61. PubMed ID: 7674597
    [No Abstract]   [Full Text] [Related]  

  • 9. Increased fibronectin incorporation into extracellular matrix in response to platelet-derived growth factor is mediated by transforming growth factor beta.
    McKay NG; Power DA; MacLeod AM; Haites NE
    Exp Nephrol; 1995; 3(2):142. PubMed ID: 7773636
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunoregulatory and fibrogenic activities of cyclosporine: a unifying hypothesis based on transforming growth factor-beta expression.
    Khanna A; Li B; Sharma VK; Suthanthiran M
    Transplant Proc; 1996 Aug; 28(4):2015-8. PubMed ID: 8769140
    [No Abstract]   [Full Text] [Related]  

  • 11. [Transforming growth factor beta: its mechanism of action and clinical significance].
    Kekow J; Gross WL
    Dtsch Med Wochenschr; 1992 Feb; 117(6):228-35. PubMed ID: 1310463
    [No Abstract]   [Full Text] [Related]  

  • 12. FK506 inhibits the enhancing effects of TGF-beta on wound healing in a rabbit dermal ulcer model.
    Hasegawa T; Sumiyoshi K; Tsuchihashi H; Ikeda S; Nakao A; Ogawa H
    J Dermatol Sci; 2007 Jul; 47(1):37-40. PubMed ID: 17416487
    [No Abstract]   [Full Text] [Related]  

  • 13. Blocking of angiotensin II is more than blocking of transforming growth factor-beta.
    Daniel C
    Kidney Int; 2008 Sep; 74(5):551-3. PubMed ID: 18709023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Appearance of Langerhans cells in the epidermis of Tgfb1(-/-) SCID mice: paracrine and autocrine effects of transforming growth factor-beta 1 and -beta 2(1).
    Thomas RM; Belsito DV; Huang C; Chen Lz LZ; Ormsby I; Simmons WJ; Cowin P; Shaw J; Doetschman T; Thorbecke GJ
    J Invest Dermatol; 2001 Dec; 117(6):1574-80. PubMed ID: 11886525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FK778 ameliorates post-transplant expression of fibrogenic growth factors and development of chronic rejection changes in rat kidney allografts.
    Rintala JM; Savikko J; Rintala SE; von Willebrand E
    Nephrol Dial Transplant; 2008 Nov; 23(11):3446-55. PubMed ID: 18558624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transforming growth factor-beta. An interesting candidate for clinical use].
    Heldin CH; Miyazono K
    Lakartidningen; 1995 Apr; 92(15):1569-72. PubMed ID: 7715279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The transforming growth factor-beta system and the kidney.
    Sharma K; Ziyadeh FN
    Semin Nephrol; 1993 Jan; 13(1):116-28. PubMed ID: 8381979
    [No Abstract]   [Full Text] [Related]  

  • 18. Transforming growth factor beta2-induced myofibroblastic differentiation of human retinal pigment epithelial cells: regulation by extracellular matrix proteins and hepatocyte growth factor.
    Gamulescu MA; Chen Y; He S; Spee C; Jin M; Ryan SJ; Hinton DR
    Exp Eye Res; 2006 Jul; 83(1):212-22. PubMed ID: 16563380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of renal disease: is it enough to inhibit the action of angiotensin II?
    Dussaule JC; Chatziantoniou C
    Cell Death Differ; 2007 Jul; 14(7):1343-9. PubMed ID: 17396129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Receptors and functions of TGF-beta, a crucial cytokine in wound healing].
    García-Sainz JA; Vilchis-Landeros MM; Juárez P; López-Casillas F; Hernández-Pando R; Massagué J
    Gac Med Mex; 2003; 139(2):126-43. PubMed ID: 12754948
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.